Zomedica Corp. Partners with World Equestrian Center to Elevate Equine Health
In a significant move to enhance veterinary care for elite equine athletes, Zomedica Corp., a leading veterinary biopharmaceutical company, has announced a strategic partnership with the World Equestrian Center - Ocala (WEC). This collaboration designates Zomedica’s PulseVet shock wave device as the official shock wave therapy provider at one of the premier equestrian venues globally.
Innovative Partnership for Equine Health
The partnership, announced on July 10, 2025, aims to bring cutting-edge shock wave therapy to the forefront of equine care. The PulseVet device, known for its non-invasive treatment of musculoskeletal injuries, will now be prominently featured at WEC - Ocala. This initiative not only underscores Zomedica’s commitment to advancing animal health through innovative technologies but also enhances the show experience for equine athletes and their caretakers.
Broad Visibility and Educational Resources
Through this strategic sponsorship, the PulseVet shock wave device will enjoy extensive visibility across the WEC Ocala property. This includes branded signage in competition arenas, digital scoreboard promotions, and features in the WEC Weekly newsletter and World Equestrian Center Magazine. Additionally, the PulseVet team will provide on-site educational resources and promotional materials to support equine veterinarians and caretakers, further solidifying the partnership’s impact on the equestrian community.
Hospitality and Promotional Privileges
The agreement also includes hospitality privileges during WEC events, offering discounted lodging and VIP access to Zomedica representatives. This aspect of the partnership not only facilitates closer collaboration between Zomedica and the equestrian community but also provides an opportunity for Zomedica to showcase its commitment to equine health and wellness.
A Game-Changer in Equine Therapy
Trudy Gage, Vice President of Equine Sales at Zomedica, described the partnership as a “game-changer” in bringing world-class therapy to a world-class venue. This sentiment reflects the broader vision of Zomedica to lead in the veterinary health sector by offering innovative solutions that meet the evolving needs of veterinarians and their animal patients.
Zomedica Corp.: A Brief Overview
Zomedica Corp., operating in the health care sector with a focus on veterinary biopharmaceuticals, serves North American customers by offering drug discovery and development for pet health. Despite facing financial challenges, as indicated by its negative price-earnings ratio and fluctuating stock price, Zomedica continues to pursue strategic initiatives that align with its mission to advance animal health. With a market capitalization of approximately $52.57 million, Zomedica remains committed to innovation and strategic partnerships that enhance its offerings and impact in the veterinary health industry.
This partnership with the World Equestrian Center - Ocala marks a significant milestone for Zomedica, reinforcing its position as a leader in veterinary health innovation and its dedication to improving the lives of animals through advanced therapeutic solutions.